Last week’s MM&M webcast titled “From Selling Pills to Selling Health Outcomes” was packed with thought provoking material. Joining the podcast were Daniel Hawkins (Clarion Healthcare Consulting), Dennis Urbaniak (Sanofi-Aventis) and Dan Rubin (inVentiv Patient …
Read the full story »
So just as we’re writing about research pharma buying into generics companies to increase their presence in emerging markets, we see on the F.A.Z. Insitute’s Chemical Newsflash that Sanofi-Aventis, worlds 6th largest pharma company, has …
Although we’ve seen a huge increase in the number of clients going straight to purchasing white-label formulations products, basically the switch for European generics companies from manufacturing to marketing, CEE markets still have low manufacturing …
